HeraMED Limited announced that Hapvida had extended its subscription for HeraCARE SaaS and cloud monitoring services for a further 24 months. Hapvida services customers nationwide, through a network of 96 hospitals and 966 clinics. The combination of the HeraBEAT device and HeraCARE cloud monitoring services are currently being used in the Hapvida hospitals as their primary pregnancy monitoring tool, in place of the traditional and much more expensive CTG pregnancy monitoring machines. Under the previous commercialisation strategy, HeraBEAT devices were purchased, however under the new agreement, a per user per month subscription model has been adopted. Hapvida have elected to make an upfront payment of USD 45,000 for the 24-month extension and negotiations are continuing in relation to the purchase of additional HeraBEAT devices.